St. Peter, Germany

Manfred F Herrmann

This inventor holds 45 USPTO granted patents and 1 published patent application, primarily in Pharmaceutical Chemistry. Top assignees: Warner-Lambert Company, Godecke Aktiengesellschaft, Other. Active years: 1976-1999.

USPTO Granted Patents = 45 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 339(Granted Patents)


Location History:

  • Saint Peter, DE (1976)
  • Gundelfingen, DE (1976 - 1978)
  • 7811 St. Peter, DE (1981)
  • 6700 Ludwigshafen, DE (1982)
  • St. Peter, DE (1976 - 1990)
  • Ulm/Donau, DE (1999)

Company Filing History:


Years Active: 1976-1999

Loading Chart...
Areas of Expertise:
Thiazolidinone Derivatives
Cyclic Amino Acids
Phenothiazine Sulphoximides
N-Phenylbenzamide Derivatives
Dibenzyl Glycolic Acid Derivatives
Tricyclic Sulphoximides
Pulmonary Thrombosis
Cardiovascular Treatment
Heterocyclic Compounds
Amino Acid Derivatives
Dye Powder Formulation
Pharmaceutical Compositions
45 patents (USPTO):Explore Patents

Title: Manfred F. Herrmann: A Pioneer in Pharmaceutical Innovations

Introduction

Manfred F. Herrmann is a renowned inventor and researcher based in St. Peter, Germany. With an impressive portfolio comprising 42 patents, his contributions have significantly impacted the field of pharmaceuticals. Discovering innovative solutions for medical challenges remains a hallmark of his career.

Latest Patents

Manfred's latest patents focus on N-phenylbenzamide derivatives, which are critical in treating refractory tumors in mammals. The derivatives described in these recent patents include the general formula I, where radicals R¹, R², and R³ can vary between hydrogen atoms or methyl radicals. These compounds, along with their pharmacologically acceptable salts, showcase potential in controlling malignant, proliferative, and autoimmune diseases, as well as in providing immunosuppressive therapy during grafting procedures.

Career Highlights

Throughout his career, Manfred F. Herrmann has worked with prestigious companies, including Warner-Lambert Company and Godecke Aktiengesellschaft. His extensive experience has enabled him to drive forward innovations that address critical health issues, leading to valuable advancements in medical treatments.

Collaborations

Manfred has collaborated with notable colleagues, including Gerhard Satzinger and Edgar Fritschi. These partnerships have fostered a rich environment for innovative thinking and have played a vital role in the development of his patented inventions.

Conclusion

Manfred F. Herrmann exemplifies the spirit of innovation in the pharmaceutical industry. With his numerous patents and collaborative efforts with esteemed colleagues, he continues to contribute significantly to advancements in medical therapies. His work not only reflects his dedication as an inventor but also underscores the importance of innovation in addressing the challenges faced in healthcare today.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…